-
Since 1998, researchers at the viral and Rickettsial Disease Laboratory in Richmond, CA (near Berkeley) have conducted a large-scale epidemiologic project to identify causes of encephalitis in California.
-
The American Heart Association last published guidelines on the use of antibiotic prophylaxis for the prevention of infective endocarditis in 1997.
-
In April, the United States Food and Drug Administration announced the approval of the first human vaccine against H5N1 Avian Influenza virus.
-
Gonococcal Infections, CDC's Updated Treatment; Head Lice Malathion
First-Line Treatment; Statins, May Cut the Risk of Cataracts; FDA Actions
-
-
After a 2 year lull with few such reports, the CDC was informed of 10 cases of severe community-acquired pneumonia (CAP) due to MRSA in previously generally healthy individuals in Louisiana and Georgia in just the 2 months of December 2006 and January 2007.
-
The possible presence of 16 different respiratory viruses, including human bocavirus, was tested by quantitative polymerase chain reaction (PCR) (16 viruses), virus culture (9 viruses), and antigen detection (7 viruses) of nasopharyngeal aspirates and also acute- and convalescent-phase serologies (7 viruses) from 259 children (range, 3 months to 15 years; median age, 1.6 years) hospitalized for acute wheezing.
-
Since the publication of the initial IDSA Guidelines for the management of community acquired pneumonia in 2003, and their implementation by JHACO and the Centers for Medicare and Medicaid Services (CMS) in 2004 as a "quality standard" for hospital care and reimbursement, hospital administrators have been scrambling to improve their numbers.
-
ACTG 328 was a multicenter trial that studied HIV-1 infected adults without active AIDS-defining illnesses and with CD4+ lymphocyte counts between 50 and 350/uL. Patients were protease inhibitor (PI) and IL-2 naïve but may have received prior nucleoside analogue therapy.
-
Data collected by the Active Bacterial Core surveillance (ABCs) system in 2005 found that the incidence of invasive MRSA infections in patients undergoing dialysis was 45.2 per 1,000 population, an incidence far in excess of that estimated for the general population (0.2 to 0.4 per 1,000 population).
